VIVUS does not undertake an obligation to update or revise any forward-looking statement.
VIVUS不承担义务更新或修改任何前瞻性陈述。
These forward-looking statements are based on VIVUS' current expectations and actual results could differ materially.
这些前瞻性声明是基于VIVUS目前预期和实际结果可能大不相同。
In July, the FDA's expert panel recommended against another proposed diet drug, Qnexa, made by Vivus inc., because of safety issues that included heart palpitations.
今年七月，美国食品药品监督管理局的专家小组就已经因为包括心悸在内的安全问题建议撤销Vivus公司生产的减肥药Qnexa。
Vivus Inc. Thursday will take a key step in gaining Food and Drug Administration approval of its experimental weight-loss drug Qnexa when it faces an agency panel of outside experts.
周四Vivus公司的减肥药物Qnexa将接受外部评审专家评价，这是该药物获得美国食品药品监督管理局批准的重要一步。
Vivus Inc. Thursday will take a key step in gaining Food and Drug Administration approval of its experimental weight-loss drug Qnexa when it faces an agency panel of outside experts.
周四Vivus公司的减肥药物Qnexa将接受外部评审专家评价，这是该药物获得美国食品药品监督管理局批准的重要一步。
应用推荐